Somalogic said this week that it has named Dan Muehl as chief financial officer.
Muehl was previously CFO of OPX Biotechnologies. Before that he was vice president of finance at Pharmion as well as CFO at firms including Repligen, Physiometrix, and Number Nine Visual Technology.
Opko Health said this week it has named Adam Logal senior vice president, chief financial officer, succeeding Juan Rodriguez, who will continue to consult for the company.
Logal was previously vice president, finance, chief accounting officer at Opko.